EUVIMEDEUVIMED entdecken
Crossref

Initial Experience of Metabolic Imaging With Hyperpolarized [1‐ 13 C ]pyruvate MRI in Kidney Transplant Patients

Xiaoxi Liu iD, Ying-Chieh Lai, Di Cui iD, Shiang-Cheng Kung, Meyeon Park, Zoltan Laszik, Peder E Z Larson iD, Zhen J Wang

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Xiaoxi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Magnetic Resonance Imaging, Pyruvic Acid, Kidney. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney transplant is the treatment of choice for patients with end‐stage renal disease. Early detection of allograft injury is important to delay or prevent irreversible damage.

Purpose

To investigate the feasibility of hyperpolarized (HP) [1‐ 13 C]pyruvate MRI for assessing kidney allograft metabolism. Study Type Prospective. Subjects Six participants (mean age, 45.2 ± 12.4 years, two females) scheduled for kidney allograft biopsy and five patients (mean age, 59.6 ± 10.4 years, two females) with renal cell carcinoma (RCC). Field Strength/Sequence Three Tesla, T2‐weighted fast spin echo, multi‐echo gradient echo, single shot diffusion‐weighted echo‐planar imaging, and time‐resolved HP 13 C metabolite‐selective imaging. Assessment Five of the six kidney allograft participants underwent biopsy after MRI. Estimated glomerular filtration rate (eGFR) and urine protein‐to‐creatine ratio (uPCR) were collected within 4 weeks of MRI. Kidney metabolism was quantified from HP [1‐ 13 C]pyruvate MRI using the lactate‐to‐pyruvate ratio in allograft kidneys and non‐tumor bearing kidneys from RCC patients. Statistical Tests Descriptive statistics (mean ± SD).

Results

Biopsy was performed a mean of 9 days (range 5–19 days) after HP [1‐ 13 C]pyruvate MRI. Three biopsies were normal, one showed low‐grade fibrosis and one showed moderate microvascular inflammation. All had stable functioning allografts with eGFR >60 mL/min/1.73 m 2 and normal uPCR. One participant who did not undergo biopsy had reduced eGFR of 49 mL/min/1.73 m 2 and elevated uPCR. The mean lactate‐to‐pyruvate ratio was 0.373 in participants with normal findings (N = 3) and 0.552 in participants with abnormal findings (N = 2). The lactate‐to‐pyruvate ratio was highest (0.847) in the participant with reduced eGFR and elevated uPRC. Native non‐tumor bearing kidneys had a mean lactate‐to‐pyruvate ratio of 0.309. Data Conclusion Stable allografts with normal findings at biopsy showed lactate‐to‐pyruvate ratios similar to native non‐tumor bearing kidneys, whereas allografts with abnormal findings showed higher lactate‐to‐pyruvate ratios. Evidence Level 2 Technical Efficacy Stage 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationMagnetic Resonance ImagingPyruvic AcidKidneyHumansFemaleMaleMiddle AgedProspective StudiesAdultCarbon IsotopesCarcinoma, Renal CellKidney NeoplasmsAllograftsBiopsyFeasibility StudiesGlomerular Filtration Rate

Stichwörter der Autor:innen

[1‐13C]lactate[1‐13C]pyruvatehyperpolarized 13Ckidney transplant

Substanzen

Pyruvic AcidCarbon IsotopesCarbon-13

Autor:innen und Institutionen

  • Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
  • Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
  • Department of Medicine, University of California San Francisco Medical Center, San Francisco, California, USA.
  • Department of Pathology, University of California San Francisco Medical Center, San Francisco, California, USA.

ORCID-Profile: Xiaoxi Liu, Di Cui, Peder E Z Larson

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • National Institute of Health

Zitieren

APA

Liu, X., Lai, Y. C., Cui, D., Kung, S. C., Park, M., Laszik, Z., Larson, P. E. Z., & Wang, Z. J. (2025). Initial Experience of Metabolic Imaging With Hyperpolarized [1‐ 13 C ]pyruvate MRI in Kidney Transplant Patients. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29580

Vancouver

Liu X, Lai YC, Cui D, Kung SC, Park M, Laszik Z, et al. Initial Experience of Metabolic Imaging With Hyperpolarized [1‐ 13 C ]pyruvate MRI in Kidney Transplant Patients. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29580

BibTeX
@article{Liu2025,
  author = {Liu, Xiaoxi and Lai, Ying-Chieh and Cui, Di and Kung, Shiang-Cheng and Park, Meyeon and Laszik, Zoltan and Larson, Peder E Z and Wang, Zhen J},
  title = {Initial Experience of Metabolic Imaging With Hyperpolarized [1‐ 13 C ]pyruvate MRI in Kidney Transplant Patients},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29580}
}
Kostenlos starten →